Avalere: Providers Face 40% Hit To Part B Reimbursements Under Dem Drug Price Reforms

Providers could face a 40% cut on average to their Medicare Part B drug reimbursements under legislation that gives Medicare the power to negotiate a small amount of drug prices in Parts B and D, a new analysis finds. The analysis, released Thursday by consulting firm Avalere, examines the effect of a drug pricing negotiation ...

Read More

No Sanctions Over Deficiencies At California Virus Test Lab

California’s new coronavirus testing laboratory won’t face sanctions for what state officials had called “significant deficiencies” that a whistleblower said threatened the accuracy of its results, authorities said Monday. The Valencia Branch Laboratory was found to have problems with training and record-keeping but authorities couldn’t substantiate reports stemming from a whistleblower that the lab destroyed ...

Read More

Federal Appeals Court Affirms Stay On Biden Vaccine Mandate For Businesses

A federal appeals court has upheld its stay on President Biden’s vaccine-or-test mandate for companies with at least 100 employees.

Read More

Kaiser Permanente, Unions Reach Labor Deal To Avert Strike

An alliance of unions representing 50,000 Kaiser Permanente workers in California, Oregon and six other states called off a strike notice after reaching a tentative labor deal Saturday with the health care network.

Read More

California Wants All Adults To Get Booster Shots. But Making An Appointment Is A Challenge

Health officials in California want everyone 18 and older to get COVID-19 booster shots ahead of the holiday season. But there is still widespread confusion about who can book an appointment and how. That’s because most online vaccination scheduling systems — including the state’s MyTurn appointment site — still show the specific eligibility categories to ...

Read More

Dems’ Bitter Pill: Popular Health Provisions Won’t Kick In Until After The Midterms

Democrats are close to making good on long-held promises to lower prescription drug costs and make health care more affordable. The rub? Voters won’t feel much of it until after the 2022 elections. The party is increasingly banking its midterm prospects on passage of the president’s domestic agenda in the coming weeks, convinced that it ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square